Vicplas International Past Earnings Performance

Past criteria checks 0/6

Vicplas International's earnings have been declining at an average annual rate of -14.8%, while the Medical Equipment industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 7.2% per year.

Key information

-14.8%

Earnings growth rate

-15.0%

EPS growth rate

Medical Equipment Industry Growth16.4%
Revenue growth rate7.2%
Return on equity-1.8%
Net Margin-1.3%
Last Earnings Update31 Jul 2024

Recent past performance updates

Recent updates

We Think Vicplas International (SGX:569) Has A Fair Chunk Of Debt

Dec 03
We Think Vicplas International (SGX:569) Has A Fair Chunk Of Debt

The Returns At Vicplas International (SGX:569) Aren't Growing

Aug 20
The Returns At Vicplas International (SGX:569) Aren't Growing

Risks To Shareholder Returns Are Elevated At These Prices For Vicplas International Ltd (SGX:569)

Jun 21
Risks To Shareholder Returns Are Elevated At These Prices For Vicplas International Ltd (SGX:569)

Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

Apr 21
Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

More Unpleasant Surprises Could Be In Store For Vicplas International Ltd's (SGX:569) Shares After Tumbling 25%

Mar 15
More Unpleasant Surprises Could Be In Store For Vicplas International Ltd's (SGX:569) Shares After Tumbling 25%

Returns At Vicplas International (SGX:569) Are On The Way Up

Jan 31
Returns At Vicplas International (SGX:569) Are On The Way Up

Here's Why Vicplas International (SGX:569) Can Manage Its Debt Responsibly

Dec 15
Here's Why Vicplas International (SGX:569) Can Manage Its Debt Responsibly

Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

Jun 15
Does Vicplas International (SGX:569) Have A Healthy Balance Sheet?

Here's What To Make Of Vicplas International's (SGX:569) Decelerating Rates Of Return

Sep 22
Here's What To Make Of Vicplas International's (SGX:569) Decelerating Rates Of Return

I Ran A Stock Scan For Earnings Growth And Vicplas International (SGX:569) Passed With Ease

May 22
I Ran A Stock Scan For Earnings Growth And Vicplas International (SGX:569) Passed With Ease

Returns At Vicplas International (SGX:569) Appear To Be Weighed Down

May 04
Returns At Vicplas International (SGX:569) Appear To Be Weighed Down

These 4 Measures Indicate That Vicplas International (SGX:569) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Vicplas International (SGX:569) Is Using Debt Reasonably Well

Vicplas International Ltd (SGX:569) Stock's On A Decline: Are Poor Fundamentals The Cause?

Mar 11
Vicplas International Ltd (SGX:569) Stock's On A Decline: Are Poor Fundamentals The Cause?

Could The Vicplas International Ltd (SGX:569) Ownership Structure Tell Us Something Useful?

Feb 18
Could The Vicplas International Ltd (SGX:569) Ownership Structure Tell Us Something Useful?

If You Like EPS Growth Then Check Out Vicplas International (SGX:569) Before It's Too Late

Feb 03
If You Like EPS Growth Then Check Out Vicplas International (SGX:569) Before It's Too Late

Is There More To The Story Than Vicplas International's (SGX:569) Earnings Growth?

Jan 19
Is There More To The Story Than Vicplas International's (SGX:569) Earnings Growth?

Here's What To Make Of Vicplas International's (SGX:569) Returns On Capital

Jan 06
Here's What To Make Of Vicplas International's (SGX:569) Returns On Capital

Vicplas International (SGX:569) Has Gifted Shareholders With A Fantastic 194% Total Return On Their Investment

Dec 22
Vicplas International (SGX:569) Has Gifted Shareholders With A Fantastic 194% Total Return On Their Investment

Weak Financial Prospects Seem To Be Dragging Down Vicplas International Ltd (SGX:569) Stock

Dec 07
Weak Financial Prospects Seem To Be Dragging Down Vicplas International Ltd (SGX:569) Stock

Is Vicplas International (SGX:569) Using Too Much Debt?

Nov 22
Is Vicplas International (SGX:569) Using Too Much Debt?

Revenue & Expenses Breakdown

How Vicplas International makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SGX:569 Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 24106-1360
30 Apr 241120370
31 Jan 241192390
31 Oct 231263400
31 Jul 231334410
30 Apr 231365420
31 Jan 231396430
31 Oct 221388430
31 Jul 221379430
30 Apr 2213210410
31 Jan 2212710390
31 Oct 2112310370
31 Jul 2112010360
30 Apr 211119340
31 Jan 211028320
31 Oct 20976300
31 Jul 20925290
30 Apr 20926290
31 Jan 20936290
31 Oct 19885280
31 Jul 19834270
30 Apr 19793260
31 Jan 19753250
31 Oct 18743240
31 Jul 18734240
30 Apr 18713230
31 Jan 18703220
31 Oct 17693210
31 Jul 17673210
30 Apr 17704220
31 Jan 17735220
31 Oct 16765220
31 Jul 16795230
30 Apr 16796230
31 Jan 16786230
31 Oct 15776220
31 Jul 15766210
30 Apr 15743210
31 Jan 1572-1210
31 Oct 1468-2200
31 Jul 1465-4200
30 Apr 1468-3210
31 Jan 1471-2220

Quality Earnings: 569 is currently unprofitable.

Growing Profit Margin: 569 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 569 is unprofitable, and losses have increased over the past 5 years at a rate of 14.8% per year.

Accelerating Growth: Unable to compare 569's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 569 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3.8%).


Return on Equity

High ROE: 569 has a negative Return on Equity (-1.83%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:54
End of Day Share Price 2024/12/18 00:00
Earnings2024/07/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vicplas International Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Boon Chong TngCGS International